About Us
Product Catalog
Science-driven · Innovation-led · Craftsmen of Proteins · Uniquely Empowered
News
Insights_Stay Updated
Yinjia Bio and Intelligent Biosystem Officially Sign Strategic Cooperation Agreement to Jointly Advance a New Paradigm of AI-Assisted Protein Synthesis with Automated High-Throughput Dry-Wet Closed Loop
Recently, Yinjia (Shanghai) Biosciences ("Yinjia Bio") and Intelligent Biosystem officially signed a strategic cooperation agreement in Shanghai.The n
Yinjia Bio was invited to attend the "Biomanufacturing" Institution Day, where its AI-driven protein innovation attracted great attention from investors.
In early April 2026, against the backdrop of the "15th Five-Year Plan" designating biomanufacturing as a core future industry track, Hangzhou Yuhuangs
Honored Again! Yinjia Bio Named Among CHC-CITIC Securities' "Top 50 Most Investable Healthcare Companies 2024"
On May 15, 2025, the "2024 China Healthcare Industry Investment and Financing Honor Roll" was officially announced. Yinjia Bio was recognized on the "2024 Top 50 Most Investable Healthcare Companies" list for its innovative R&D capabilities, forward-looking strategic planning, and industry-leading practices.
YinJia Bio has joined hands with BioGeometry to forge a strategic partnership, propelling "Protein Artisan" to a new height of digital intelligence.
On May 31, 2024, Yinjia (Shanghai) Biomedical Technology Co., Ltd. (referred to as "Yinjia Bio") and Beijing BioGeometry Biotechnology Co., Ltd. (refe
Yinjia Bio Selected for Future Healthcare 100, Injecting New Vitality into the Global Pharmaceutical Industry
On May 6, the 7th Future Healthcare 100 Summit, co-organized by Shanghai Zhangjiang Group and VB100, was held. Yinjia (Shanghai) Biomedical Technology
Yinjia Bio Secures Nearly RMB 100 Million in Series A Financing to Accelerate Development of Novel Synthetic Biology Platform for Protein Synthesis
Yinjia (Shanghai) Biosciences (“Yinjia Bio”) recently closed its Series A financing round worth nearly RMB 100 million. The round was led by CMB Inter
-
0 +Established in 2020
-
0 +Nationwide Service Network
-
0 +Patents Granted
-
0 +Partners
-
0 +Reagent Products
-
0 +Core Strategic Partners
